Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.9%

3 terminated/withdrawn out of 61 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

54%

33 trials in Phase 3/4

Results Transparency

20%

9 of 45 completed trials have results

Key Signals

2 recruiting9 with results

Enrollment Performance

Analytics

Phase 4

25(54.3%)

Phase 3

8(17.4%)

Phase 1

7(15.2%)

Phase 2

5(10.9%)

N/A

1(2.2%)

46Total

Phase 4(25)

Phase 3(8)

Phase 1(7)

Phase 2(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (61)

Showing 20 of 61 trials

NCT06757764Phase 4Recruiting

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

Role: collaborator

NCT03406286Completed

Samsca PMS in ADPKD Patients

Role: lead

NCT06674291Not Yet Recruiting

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Role: lead

NCT03423680Phase 3Recruiting

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Role: lead

NCT05048069Unknown

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

Role: lead

NCT03709017Unknown

Iclusig PMS in CML or Ph+ALL Patients

Role: lead

NCT01142284Phase 2Completed

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Role: lead

NCT03949894Phase 4Completed

Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease

Role: lead

NCT01197066Phase 3Completed

Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis

Role: lead

NCT01711333Phase 4Completed

A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Role: lead

NCT01000467Phase 4Completed

Pharmacokinetics Study for Probucol

Role: lead

NCT00549978Phase 4Completed

Safety and Pharmacokinetics of Probucol and Cilostazol

Role: lead

NCT01552590Phase 4Terminated

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

Role: lead

NCT03386851Completed

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Role: lead

NCT03376763Phase 4Completed

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Role: lead

NCT03470233Completed

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Role: lead

NCT01961882Phase 2Completed

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Role: collaborator

NCT04189705Phase 3Completed

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Role: lead

NCT04407312Phase 4Unknown

Cilostazol and Endothelial Progenitor Cell